(Q30235074)

English

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 June 2017

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 June 2017

multiple drug resistance

0 references

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Hendrik Simon Schaaf

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Christoph Lange

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Charles Robert Horsburgh

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gavin J Churchyard

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Helen McIlleron

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nesri Padayatchi

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Robin M. Warren

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

32

object named as

Dick Menzies

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

37

object named as

Eric Goemaere

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paul van Helden

12

object named as

Paul van Helden

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

7

object named as

Jennifer Furin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Eric Nuermberger

34

object named as

Eric Nuermberger

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

object named as

Sachin R Atre

24

0 references

Matthias Merker

object named as

Matthias Merker

14

0 references

object named as

Grant Theron

11

0 references

object named as

Leslie London

9

0 references

object named as

Stefan Niemann

13

0 references

object named as

Keertan Dheda

1

0 references

29

object named as

Zarir F Udwadia

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Kelly E Dooley

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Megan Murray

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Edward A Nardell

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Erica Lessem

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

David Dowdy

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Annelies Van Rie

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jotam G Pasipanodya

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Camilla Rodrigues

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Frik A Sirgel

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Aliasgar Esmail

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Kwok Chiu Chang

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Anneke C Hesseling

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Kevin P Fennelly

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ernesto Jaramillo

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Marcus Low

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Carolina Morán Jara

40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ruth McNerney

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 June 2017

The Lancet. Respiratory medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Global burden of drug-resistant tuberculosis in children: a mathematical modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fitness cost of drug resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutagenesis and stress responses induced in Escherichia coli by hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A four-year nationwide molecular epidemiological study in Estonia: risk factors for tuberculosis transmission

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for multidrug resistant tuberculosis in Europe: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review and meta-analysis of molecular epidemiological studies of tuberculosis: development of a new tool to aid interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug resistant tuberculosis in diabetes mellitus: a retrospective study from south India.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of diabetic control status on the clinical features of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus and tuberculosis facts and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for drug resistant tuberculosis in southeast Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis control in China: use of modelling to develop targets and policies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the epidemiological relevance of variable-number tandem-repeat genotyping of Mycobacterium bovis and comparison of the method with IS6110 restriction fragment length polymorphism analysis and spoligotyping

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Origin and Interstate Spread of a New York City Multidrug-Resistant Mycobacterium tuberculosis Clone Family

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of drug-resistant tuberculosis in an epidemic area

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year population-based evaluation of standardized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis drug resistance mutation database

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The fitness costs of antibiotic resistance mutations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Will tuberculosis become resistant to all antibiotics?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution and transmission of drug-resistant tuberculosis in a Russian population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

National survey of drug-resistant tuberculosis in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The competitive cost of antibiotic resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The biological cost of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fitness of antibiotic-resistant microorganisms and compensatory mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Streptomycin resistance in pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in molecular epidemiology of drug-resistant tuberculosis in Republic of Karelia, Russian Federation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular structure of Mycobacterium tuberculosis population in Russia and its interaction with neighboring countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium tuberculosis Beijing family: analysis of the epidemiological and clinical factors associated with an emerging lineage in the urban area of Milan.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spread

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phylogenetic lineages of tuberculosis isolates in New Zealand and their association with patient demographics.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MDR-TB in Finland--still rare despite the situation in our neighbouring countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clustering of Mycobacterium tuberculosis strains from foreign-born patients in Korea

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant Mycobacterium tuberculosis strain from Equatorial Guinea detected in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The movement of multidrug-resistant tuberculosis across borders in East Africa needs a regional and global solution

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term molecular surveillance of multidrug-resistant tuberculosis in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Estonia lauded for tuberculosis control efforts

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis in New York City--turning the tide

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic stewardship for drug resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifying Likely Transmission Pathways within a 10-Year Community Outbreak of Tuberculosis by High-Depth Whole Genome Sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole genome sequencing of Mycobacterium tuberculosis for detection of recent transmission and tracing outbreaks: A systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approach.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The implications of whole-genome sequencing in the control of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

XDR-TB transmission in London: Case management and contact tracing investigation assisted by early whole genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterial DNA extraction for whole-genome sequencing from early positive liquid (MGIT) cultures

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical use of whole genome sequencing for Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Remote monitoring of Xpert® MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The prospective evaluation of the TB strain typing service in England: a mixed methods study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Promoting adherence to treatment for tuberculosis: the importance of direct observation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The problem of self-administration of drugs; with particular reference to pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Directly observed therapy for tuberculosis: history of an idea

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New York City's tuberculosis control efforts: the historical limitations of the "war on consumption"

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired Drug Resistance Because of Pharmacokinetic Variability in a Young Child With Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extremely High Mutation Rate of HIV-1 In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Synchronized replication of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A replication clock for Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Directly observed therapy for treating tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Directly observed therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Directly observed therapy for treating tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired drug resistance during inadequate therapy in a young child with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum drug concentrations predictive of pulmonary tuberculosis outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid’s Bactericidal Activity Ceases because of the Emergence of Resistance, Not Depletion ofMycobacterium tuberculosisin the Log Phase of Growth

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired resistance of Mycobacterium tuberculosis to bedaquiline

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological variability and the emergence of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The pyrazinamide susceptibility breakpoint above which combination therapy fails

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New susceptibility breakpoints and the regional variability of MIC distribution in Mycobacterium tuberculosis isolates

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge [Short communication]

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An upstream truncation of the furA-katG operon confers high-level isoniazid resistance in a Mycobacterium tuberculosis clinical isolate with no known resistance-associated mutations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rifampin drug resistance tests for tuberculosis: challenging the gold standard

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-susceptibility testing in tuberculosis: methods and reliability of results

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Assembly of the Mycobacterial Cell Wall

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Silent mutation in rpoB detected from clinical samples with rifampin-susceptible Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Compensatory Mutations of Rifampin Resistance Are Associated with Transmission of Multidrug-Resistant Mycobacterium tuberculosis Beijing Genotype Strains in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective whole genome amplification for resequencing target microbial species from complex natural samples

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selected questions and controversies about bedaquiline: a view from the field.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid pharmacokinetics in children treated for respiratory tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

β-Lactams against Tuberculosis--New Trick for an Old Dog?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of antituberculosis drugs: a new proposal based on the most recent evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers for tuberculosis disease activity, cure, and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers for tuberculosis disease activity, cure, and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative and end-of-life care in the global response to multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Integration of antiretroviral therapy with tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of drug resistantTB in patients with HIV co-infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Endobronchial valve placement for the treatment of bronchopleural fistula: a review of the current literature

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Concordance of resistance profiles in households of patients with multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Caring for children with drug-resistant tuberculosis: practice-based recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing multidrug-resistant tuberculosis in children: review of recent developments.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hearing loss in children treated for multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Quinolone-mediated bacterial death.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Linezolid for treatment of chronic extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The association between sterilizing activity and drug distribution into tuberculosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bedaquiline: a review of human pharmacokinetics and drug-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Delamanid for multidrug-resistant pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resista

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonclinical models for antituberculosis drug development: a landscape analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental models of tuberculosis: can we trust the mouse?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Using animal models to develop new treatments for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards early inclusion of children in tuberculosis drugs trials: a consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Developmental pharmacology--drug disposition, action, and therapy in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Linezolid pharmacokinetics in pediatric patients: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of ethambutol in South African tuberculosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of bedaquiline (TMC207), a novel antituberculosis drug.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence of infection influences the epithelial lining fluid penetration of oral levofloxacin in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrapulmonary pharmacokinetics of linezolid

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid concentrations of antituberculosis agents in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Concentration of ethambutol in cerebrospinal fluid in man as a function of the non-protein-bound drug fraction in serum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Amikacin Concentration in the Cerebrospinal Fluid of Children with Acute Bacterial Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicodynamics and toxicokinetics of amikacin in the guinea pig cochlea

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Institutional tuberculosis transmission. Controlled trial of upper room ultraviolet air disinfection: a basis for new dosing guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Using a mathematical model to evaluate the efficacy of TB control measures

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Programmatic management of multidrug-resistant tuberculosis: models from three countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lay health workers and HIV care in rural Lesotho: a report from the field

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychosocial support groups for patients with multidrug-resistant tuberculosis: five years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of Extensively Drug-Resistant Tuberculosis in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nurses as providers of emotional support to patients with MDR-TB.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Infection control in households of drug-resistant tuberculosis patients co-infected with HIV in Mumbai, India

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Wind-driven roof turbines: a novel way to improve ventilation for TB infection control in health facilities

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long delays and missed opportunities in diagnosing smear-positive pulmonary tuberculosis in Kampala, Uganda: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Healthcare-seeking behavior, treatment delays and its determinants among pulmonary tuberculosis patients in rural Nigeria: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed consultation among pulmonary tuberculosis patients: a cross sectional study of 10 DOTS districts of Ethiopia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of tuberculosis transmission and the impact of household contact tracing. An agent-based simulation model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advancing palliative care as a human right

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of HIV and HIV-related diseases in the adult medical wards of a tertiary hospital in Durban, South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV treatment cascade in tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Does decentralisation of tuberculosis care influence treatment outcomes? The case of Oromia Region, Ethiopia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2817%2930079-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-2600(17)30079-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344011%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30235074&oldid=2190193384"